FDA: Here Are The New Warnings About Sleeping Pills Like Ambien, Lunesta, Sonata

“These incidents can occur after the first dose of these sleep medicines or after a longer period of treatment, and can occur in patients without any history of these behaviors and even at the lowest recommended doses,” according to FDA Acting Commissioner Ned Sharpless, M.D.

Read the full post on Forbes - Healthcare